Wall Street Experts
ver. ZuMIgo(08/25)
Mayinglong Pharmaceutical Group Co., LTD.
Rachunek Zysków i Strat
Przychody TTM (mln): 3 469
EBIT TTM (mln): 587
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
Rok finansowy |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
205 |
248 |
326 |
371 |
412 |
536 |
549 |
810 |
1,022 |
1,178 |
1,416 |
1,542 |
1,602 |
1,621 |
1,784 |
2,103 |
1,751 |
2,198 |
2,705 |
2,792 |
3,385 |
3,532 |
3,137 |
3,728 |
Przychód Δ r/r |
0.0% |
21.1% |
31.2% |
13.9% |
11.0% |
30.1% |
2.4% |
47.6% |
26.2% |
15.3% |
20.1% |
8.9% |
3.9% |
1.2% |
10.0% |
17.9% |
-16.7% |
25.5% |
23.1% |
3.2% |
21.3% |
4.4% |
-11.2% |
18.9% |
Marża brutto |
66.6% |
65.7% |
59.4% |
56.9% |
58.0% |
48.2% |
43.1% |
38.9% |
37.9% |
37.7% |
39.4% |
41.6% |
42.8% |
41.8% |
39.5% |
36.3% |
50.1% |
45.1% |
41.0% |
40.4% |
40.4% |
42.4% |
41.7% |
46.6% |
EBIT (mln) |
32 |
36 |
46 |
64 |
75 |
92 |
186 |
86 |
215 |
136 |
154 |
187 |
203 |
215 |
237 |
261 |
366 |
193 |
425 |
500 |
550 |
556 |
537 |
667 |
EBIT Δ r/r |
0.0% |
14.4% |
28.7% |
38.9% |
16.6% |
22.8% |
101.6% |
-53.8% |
149.6% |
-36.5% |
13.0% |
21.7% |
8.3% |
6.1% |
10.3% |
10.1% |
40.0% |
-47.2% |
119.7% |
17.9% |
10.0% |
1.0% |
-3.4% |
24.3% |
EBIT (%) |
15.4% |
14.5% |
14.3% |
17.4% |
18.3% |
17.2% |
33.9% |
10.6% |
21.0% |
11.6% |
10.9% |
12.2% |
12.7% |
13.3% |
13.3% |
12.4% |
20.9% |
8.8% |
15.7% |
17.9% |
16.3% |
15.7% |
17.1% |
17.9% |
Koszty finansowe (mln) |
5 |
5 |
3 |
2 |
1 |
2 |
8 |
5 |
7 |
4 |
3 |
7 |
5 |
6 |
8 |
5 |
3 |
4 |
5 |
7 |
10 |
12 |
17 |
7 |
EBITDA (mln) |
40 |
43 |
62 |
76 |
91 |
114 |
210 |
101 |
256 |
182 |
216 |
207 |
251 |
256 |
282 |
325 |
357 |
388 |
460 |
459 |
637 |
709 |
633 |
746 |
EBITDA(%) |
19.3% |
17.4% |
19.1% |
20.6% |
22.1% |
21.2% |
38.3% |
12.5% |
25.1% |
15.5% |
15.3% |
13.4% |
15.7% |
15.8% |
15.8% |
15.5% |
20.4% |
17.6% |
17.0% |
16.4% |
18.8% |
20.1% |
20.2% |
20.0% |
Podatek (mln) |
6 |
4 |
8 |
12 |
15 |
18 |
34 |
17 |
31 |
24 |
25 |
32 |
37 |
30 |
37 |
47 |
56 |
27 |
69 |
67 |
74 |
79 |
73 |
109 |
Zysk Netto (mln) |
28 |
33 |
40 |
53 |
60 |
72 |
133 |
80 |
180 |
123 |
138 |
174 |
186 |
201 |
223 |
250 |
320 |
176 |
360 |
419 |
465 |
479 |
443 |
528 |
Zysk netto Δ r/r |
0.0% |
19.6% |
20.8% |
32.3% |
14.1% |
19.7% |
85.6% |
-39.7% |
123.9% |
-32.0% |
12.4% |
26.2% |
7.2% |
8.1% |
10.8% |
12.1% |
27.9% |
-44.9% |
104.3% |
16.4% |
10.9% |
3.1% |
-7.5% |
19.1% |
Zysk netto (%) |
13.4% |
13.3% |
12.2% |
14.2% |
14.6% |
13.4% |
24.3% |
9.9% |
17.6% |
10.4% |
9.7% |
11.3% |
11.6% |
12.4% |
12.5% |
11.9% |
18.3% |
8.0% |
13.3% |
15.0% |
13.7% |
13.6% |
14.1% |
14.2% |
EPS |
0.063 |
0.0754 |
0.12 |
0.1 |
0.12 |
0.17 |
0.31 |
0.19 |
0.42 |
0.28 |
0.32 |
0.4 |
0.43 |
0.47 |
0.52 |
0.58 |
0.74 |
0.41 |
0.84 |
0.97 |
1.08 |
1.11 |
1.03 |
1.23 |
EPS (rozwodnione) |
0.063 |
0.0754 |
0.12 |
0.1 |
0.12 |
0.17 |
0.31 |
0.19 |
0.42 |
0.28 |
0.32 |
0.4 |
0.43 |
0.47 |
0.52 |
0.58 |
0.74 |
0.41 |
0.84 |
0.97 |
1.08 |
1.11 |
1.03 |
1.23 |
Ilośc akcji (mln) |
437 |
437 |
437 |
437 |
437 |
426 |
431 |
427 |
430 |
431 |
426 |
434 |
433 |
429 |
429 |
431 |
431 |
430 |
431 |
431 |
431 |
431 |
430 |
431 |
Ważona ilośc akcji (mln) |
437 |
437 |
437 |
437 |
437 |
426 |
431 |
427 |
430 |
431 |
426 |
434 |
433 |
429 |
429 |
431 |
433 |
430 |
431 |
431 |
431 |
431 |
430 |
431 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |